Access & reimbursement

Radioligand Therapy Is Building Its Evidence Base. Now Build the Infrastructure.

Alzheimer’s Treatment Moves Home. Risk Does Not.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Desmoid Tumours Are Not Benign to the People Living With Them

Pancreatic Cancer Is Forcing Regulators to Move Faster

Europe Built Seasonal COVID Campaigns. Most Older Adults Were Not Reached.

Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge

Medicare Is Coming for the Oncology Margin

New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
